Health Outcomes

• Neurological/Cognitive outcomes

Health Outcome List:

• Reviewed publications that examined — neurological/cognitive outcomes (Parkinson's disease, other neurodegenerative diseases (Manganism))

Environmental Agents

List of Environmental Agents:

• Reviewed publications that examined — metal (manganese)

Source of Environmental Agents:

• Reviewed publications that examined — inhaled manganese (hazardous air pollutant)

Economic Evaluation / Methods and Source

Type:

• Cost analysis (CA)

Cost Measures:

• Reviewed publications that examined — costs associated with Parkinson's disease, such as annual medical costs

Potential Cost Measures:

• Costs of institutionalization
• costs related to remedial care and/or education
• decline in functional capacity

Benefits Measures:

• Not available

Potential Benefits Measures:

• Not available

Location:

• Not available

Models Used:

• Not available

Models References:

• Not available

Methods Used:

• The author reviewed previous literature to analyze how manganese neurotoxicity elevates Parkinson's risk and explored the influence of aging along with the economic implications of these risks.

Sources Used:

• Rate of cell death in Parkinsonism indicates active neuropathological process (McGeer et al., 1988); Ageing and Parkinson's disease: substantia nigra regional selectivity (Fearnley and Lees, 1991); additional sources cited in publication

Economic Citation / Fundings

Citation:

• Weiss B. Economic implications of manganese neurotoxicity. NeuroToxicology. 2006. 27; 3.
• Pubmed

NIEHS Funding:

• P01ES001247; P50ES001247; P30ES001247

Other Funding: Not available